Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk
- 29 July 2013
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 22 (9), 1013-1018
- https://doi.org/10.1002/pds.3495
Abstract
Purpose To determine which medications are most commonly used by women in the first trimester of pregnancy and identify the critical gaps in information about fetal risk for those medications. Methods Self‐reported first‐trimester medication use was assessed among women delivering liveborn infants without birth defects and serving as control mothers in two large case–control studies of major birth defects. The Teratology Information System (TERIS) expert Advisory Board ratings of quality and quantity of data available to assess fetal risk were reviewed to identify information gaps. Results Responses from 5381 mothers identified 54 different medication components used in the first trimester by at least 0.5% of pregnant women, including 31 prescription and 23 over‐the‐counter medications. The most commonly used prescription medication components reported were progestins from oral contraceptives, amoxicillin, progesterone, albuterol, promethazine, and estrogenic compounds. The most commonly used over‐the‐counter medication components reported were acetaminophen, ibuprofen, docusate, pseudoephedrine, aspirin, and naproxen. Among the 54 most commonly used medications, only two had “Good to Excellent” data available to assess teratogenic risk in humans, based on the TERIS review. Conclusions For most medications commonly used in pregnancy, there are insufficient data available to characterize the fetal risk fully, limiting the opportunity for informed clinical decisions about the best management of acute and chronic disorders during pregnancy. Future research efforts should be directed at these critical knowledge gaps. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- Evolving knowledge of the teratogenicity of medications in human pregnancySeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2011
- Committee Opinion No. 494: Sulfonamides, Nitrofurantoin, and Risk of Birth DefectsObstetrics & Gynecology, 2011
- Prescription Medication Borrowing and Sharing among Women of Reproductive AgeJournal of Women's Health, 2008
- Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st centuryBirth Defects Research Part A: Clinical and Molecular Teratology, 2008
- Trends in Outpatient Prescription Drug Use and Related Costs in the USPharmacoEconomics, 2006
- Use of over-the-counter medications during pregnancyAmerican Journal of Obstetrics and Gynecology, 2005
- Report from the CDC. Changes in Selected Chronic Disease-Related Risks and Health Conditions for Nonpregnant Women 18–44 Years Old BRFSSJournal of Women's Health, 2005
- Teratogenicity of recently introduced medications in human pregnancyObstetrics & Gynecology, 2002
- EFFECT OF QUESTIONNAIRE DESIGN ON RECALL OF DRUG EXPOSURE IN PREGNANCYAmerican Journal of Epidemiology, 1986